geron corp (GERN:NASDAQ GS)
Hoyoung Huh M.D., Ph.D.
Chairman and Member of Nominating & Corporate Governance Committee, Geron Corporation
|Age||Total Calculated Compensation||This person is connected to 116 board members in 8 different organizations across 10 different industries.|
See Board Relationships
Dr. Hoyoung Huh, M.D., Ph.D., served as the Chief Executive Officer and President of BiPar Sciences, Inc. from March 3, 2008 to December 1, 2009. Dr. Huh served as the Chief Operating Officer and Head of the PEGylation Business Unit of Nektar Therapeutics from May 2007 to February 29, 2008 and served as its Senior Vice President of Business Development and Marketing. Dr. Huh is a leading advisor to biotechnology, healthcare and investment companies around the globe and ...
149 Commonwealth DrivePhone: 650-473-7700
Menlo Park, California 94025
Board Members Memberships*
Chairman and Chairman of BiPar Innovation Board
Former Director, Member of Audit Committee, Member of Compensation Committee and Member of Scientific Review Committee
Chairman and Member of Nominating & Corporate Governance Committee
Director and Chairman of Nomination Committee
Chairman of The Board
Annual Compensation*There is no Annual Compensation data available.
|Gil Van Bokkelen Ph.D.||Co-Founder, Chairman and Chief Executive Officer|
|Michael D. West Ph.D.||Chief Executive officer, President and Director|
|Christopher J. Calhoun||Co-Founder, Vice Chairman, Chief Executive Officer and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Lode Debrabandere Ph.D., MBA||Chief Executive Officer, President and Director|
Osiris Therapeutics, Inc.
|$327.3K||Compensation as of Fiscal Year 2012.|